Bangla Hunt Desk: The results of the first phase of the clinical trial of the indigenous corona vaccine ‘Covaxin’ (Covaxin) have come to light. This result has brought relief to the countrymen as well as the company. The company said on Wednesday that the vaccine had been able to produce antibodies in the body in the first phase of clinical trials and no side effects had been reported. The company said no serious problems arose after the first round of vaccinations, and that the problems were quickly cured without medication. The pain where the injection was given also healed very quickly.
Interim findings from phase 1 trial of Covaxin: After 1st vaccination, local & systemic adverse events were predominantly mild / moderate in severity & resolved rapidly, without prescribed medication. Most common adverse event was pain at injection site which resolved spontaneously https://t.co/0CinbDySG6
– ANI ()ANI) December 16, 2020